The Metastasis of Gastric Cancer and Clinical Strategy_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

梁寒

Corresponding?author：

Keywords：

胃癌; 轉移

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 梁寒. The Metastasis of Gastric Cancer and Clinical Strategy. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2012, 19(1): 8-11. doi: Copy

1.	Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics,2002[J]. CA Cancer J Clin, 2005, 55(2)：74-108.
2.	Sasako M, Sakuramoto S, Katai H,et al.Five-year outcomes of a randomized phase Ⅲ trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stageⅡ orⅢ gastric cancer[J].J Clin Oncol, 2011, 29(33)：4387-4393.
3.	Tsujitani S, Oka S, Suzuki K,et al.Prognostic factors in patients　with advanced gastric cancer treated by noncurative resection：a　multivariate analysis[J].Hepatogastroenterology, 2001, 48(41): 1504-1508.
4.	Yonemura Y, Ninomiya I, Tsugawa K,et al.Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach[J].Cancer Detect Prev, 1998, 22(2)：139-146.
5.	Kaibara N, Iitsuka Y, Kimura A,et al.Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma[J].Cancer, 1987, 60(1)：136-139.
6.	Sun Z,Xu YY,Wang ZN,et al.Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery[J].Ann Surg Oncol,2011,18(4)：1068-1080.
7.	Lee JE,Hong SP,Ahn DH,et al.The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy[J].Yonsei Med J,2011,52(1)：81-88.
8.	Karanicolas PJ,Elkin EB,Jacks LM,et al.Staging laparoscopy in the management of gastric cancer： a population-based analysis[J].J Am Coll Surg,2011,213(5)：644-651.
9.	Leake PA,Cardoso R,Seevaratnam R,et al.A systematic revi-ew of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer[J].Gastric Cancer,2011,[Epub ahead of print].
10.	Bando E,Yonemura Y,Takeshita Y,et al.Intraoperative lavage for cytological examination in 1 297 patients with gastric carcinoma[J].Am J Surg,1999,178(3)：256-262.
11.	丁友成，朱正綱，劉炳亞，等. 腹腔液胃癌細胞學與CEA mRNA檢測比較的意義[J]. 外科理論與實踐， 2003， 8(1)：37-39．.
12.	Sugarbaker PH.Peritonectomy procedures[J].Ann Surg,1995,221(1)：29-42.
13.	Marutsuka T, Shimada S, Shiomori K, et al.Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma： an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis[J].Clin Cancer Res, 2003, 9(2)：678-685.
14.	梁寒，郝希山.熱療的生物學機制[J].國外醫學：腫瘤學分冊， 2001， 28(6)：438-441．.
15.	梁寒，李景武，史玉榮，等.熱療對人類結腸癌細胞株黏附因子表達的影響[J].中華醫學雜志， 2004， 84(15)：1299-1303．.
16.	Yan TD,Cao CQ,Munkholm-Larsen S.A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy[J].World J Gastrointest Oncol,2010,2(2)：109-116.
17.	詹宏杰，梁寒，王寶貴，等.60例進展期胃癌術中熱關注化療的臨床觀察[J].中國腫瘤臨床， 2010， 37(4)：229-231.
18.	Yan TD,Black D,Savady R,et al.A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei[J].Ann Surg Oncol,2007,14(2)：484-492.
19.	Kodera Y,Imano M,Yoshikawa T,et al.A randomized phase Ⅱ trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial)[J].Jpn J Clin Oncol,2011,41(2)：283-286.
20.	Yang XJ,Huang CQ,Suo T,et al.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer： final results of a phaseⅢ randomized clinical trial[J].Ann Surg Oncol, 2011, 18(6)：1575-1581.
21.	Gilly FN,Cotte E,Brigand C,et al.Quantitative prognosticindices in peritoneal carcinomatosis[J].Eur J Surg Oncol,2006, 32(6)：597-601.
22.	Glehen O, Gilly FN, Arvieux C,et al.Peritoneal carcinomatosis from gastric cancer： a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy[J].Ann Surg Oncol, 2010, 17(9)：2370-2377.
23.	梁寒，王殿昌，孫慧，等.活性碳吸附絲裂霉素C腹腔化療的臨床實驗研究[J].中國腫瘤臨床， 2000， 27(12)：897-901．.
24.	梁寒，王仆，王曉娜，等.活性碳吸附絲裂霉素C腹腔化療預防進展期胃癌術后復發[J].中華外科雜志， 2003， 41(4)：274-277．.
25.	孟強，凌光烈，鹿曉理，等.直腸癌不同化療方法區域淋巴結內藥物濃度比較[J].中華消化外科雜志， 2007， 6(6)： 452-454．.
26.	李沛雨，劉娜，李榮，等. 術中腹腔內5-氟尿嘧啶緩釋化療劑對進展期胃癌的療效[J]. 中華消化外科雜志， 2008， 7(5)：349-350．.

1. 　Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics,2002[J]. CA Cancer J Clin, 2005, 55(2)：74-108.
2. Sasako M, Sakuramoto S, Katai H,et al.Five-year outcomes of a randomized phase Ⅲ trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stageⅡ orⅢ gastric cancer[J].J Clin Oncol, 2011, 29(33)：4387-4393.
3. Tsujitani S, Oka S, Suzuki K,et al.Prognostic factors in patients　with advanced gastric cancer treated by noncurative resection：a　multivariate analysis[J].Hepatogastroenterology, 2001, 48(41): 1504-1508.
4. Yonemura Y, Ninomiya I, Tsugawa K,et al.Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach[J].Cancer Detect Prev, 1998, 22(2)：139-146.
5. Kaibara N, Iitsuka Y, Kimura A,et al.Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma[J].Cancer, 1987, 60(1)：136-139.
6. Sun Z,Xu YY,Wang ZN,et al.Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery[J].Ann Surg Oncol,2011,18(4)：1068-1080.
7. Lee JE,Hong SP,Ahn DH,et al.The role of 18F-FDG PET/CT in the evaluation of gastric cancer recurrence after curative gastrectomy[J].Yonsei Med J,2011,52(1)：81-88.
8. Karanicolas PJ,Elkin EB,Jacks LM,et al.Staging laparoscopy in the management of gastric cancer： a population-based analysis[J].J Am Coll Surg,2011,213(5)：644-651.
9. Leake PA,Cardoso R,Seevaratnam R,et al.A systematic revi-ew of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer[J].Gastric Cancer,2011,[Epub ahead of print].
10. Bando E,Yonemura Y,Takeshita Y,et al.Intraoperative lavage for cytological examination in 1 297 patients with gastric carcinoma[J].Am J Surg,1999,178(3)：256-262.
11. 丁友成，朱正綱，劉炳亞，等. 腹腔液胃癌細胞學與CEA mRNA檢測比較的意義[J]. 外科理論與實踐， 2003， 8(1)：37-39．.
12. Sugarbaker PH.Peritonectomy procedures[J].Ann Surg,1995,221(1)：29-42.
13. Marutsuka T, Shimada S, Shiomori K, et al.Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma： an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis[J].Clin Cancer Res, 2003, 9(2)：678-685.
14. 梁寒，郝希山.熱療的生物學機制[J].國外醫學：腫瘤學分冊， 2001， 28(6)：438-441．.
15. 梁寒，李景武，史玉榮，等.熱療對人類結腸癌細胞株黏附因子表達的影響[J].中華醫學雜志， 2004， 84(15)：1299-1303．.
16. Yan TD,Cao CQ,Munkholm-Larsen S.A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy[J].World J Gastrointest Oncol,2010,2(2)：109-116.
17. 詹宏杰，梁寒，王寶貴，等.60例進展期胃癌術中熱關注化療的臨床觀察[J].中國腫瘤臨床， 2010， 37(4)：229-231.
18. Yan TD,Black D,Savady R,et al.A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei[J].Ann Surg Oncol,2007,14(2)：484-492.
19. Kodera Y,Imano M,Yoshikawa T,et al.A randomized phase Ⅱ trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial)[J].Jpn J Clin Oncol,2011,41(2)：283-286.
20. Yang XJ,Huang CQ,Suo T,et al.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer： final results of a phaseⅢ randomized clinical trial[J].Ann Surg Oncol, 2011, 18(6)：1575-1581.
21. Gilly FN,Cotte E,Brigand C,et al.Quantitative prognosticindices in peritoneal carcinomatosis[J].Eur J Surg Oncol,2006, 32(6)：597-601.
22. Glehen O, Gilly FN, Arvieux C,et al.Peritoneal carcinomatosis from gastric cancer： a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy[J].Ann Surg Oncol, 2010, 17(9)：2370-2377.
23. 梁寒，王殿昌，孫慧，等.活性碳吸附絲裂霉素C腹腔化療的臨床實驗研究[J].中國腫瘤臨床， 2000， 27(12)：897-901．.
24. 梁寒，王仆，王曉娜，等.活性碳吸附絲裂霉素C腹腔化療預防進展期胃癌術后復發[J].中華外科雜志， 2003， 41(4)：274-277．.
25. 孟強，凌光烈，鹿曉理，等.直腸癌不同化療方法區域淋巴結內藥物濃度比較[J].中華消化外科雜志， 2007， 6(6)： 452-454．.
26. 李沛雨，劉娜，李榮，等. 術中腹腔內5-氟尿嘧啶緩釋化療劑對進展期胃癌的療效[J]. 中華消化外科雜志， 2008， 7(5)：349-350．.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

The Metastasis of Gastric Cancer and Clinical Strategy

Abstract Full text Figures/Tables Video References Cited by

Format

Content